Tang Zeli, Wu Zhanshuai, Sun Hengchang, Zhao Lu, Shang Mei, Shi Mengchen, Jiang Hongye, Lin Zhipeng, Zhou Xinyi, Li Xuerong, Yu Xinbing, Huang Yan
Department of Cell Biology and Genetics, School of Pre-clinical Medicine, Guangxi Medical University, Nanning, China.
Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Appl Microbiol Biotechnol. 2021 Mar;105(6):2513-2526. doi: 10.1007/s00253-021-11126-z. Epub 2021 Feb 19.
Bacillus subtilis (B. subtilis) spore can serve as an ideal vehicle for expressing heterologous antigens, and elicit specific immune responses by oral administration. In previous studies, we successfully constructed the recombinant B. subtilis spores expressing cysteine protease of Clonorchis sinensis (C. sinensis, B.s-CsCP), and confirmed that oral administration of B.s-CsCP could elicit good protective immune responses in mice. In this study, Gram staining was used to observe the morphology of B.s-CsCP in different form, and the storage of liquid spores and lyophilized spores at different temperatures was compared. The mice were orally immunized with three different doses of spores (2×10, 1×10, and 5×10 CFU/day) for three times in total at biweekly interval. Then, antibody levels of mice were measured, the safety of spores was evaluated, and the changes of gut microbiota after oral gavage of spores (1×10 dose) were investigated. Results showed that B. subtilis was a typical Gram-positive bacterium, and its spore had good resistance to chemical dye. Liquid B. subtilis spores resuspended in sterile water could be stored for a long time at 4 °C or below, while lyophilized spores could be well stored even at RT and better at lower temperatures. Oral administration of B. subtilis spores to mice could stimulate both local mucosal and systemic immune responses in a dose-dependent manner without toxic side effects. Besides, beneficial bacteria producing butyrate such as Odoribacter were increased, while potential pathogens such as Escherichia-Shigella were decreased in mice intestine. Therefore, our work further confirmed that B. subtilis spores expressing CsCP could be a promising oral vaccine against C. sinensis with the advantages of stability, safety, easy storage, and promotion of intestinal health.Key Points• Recombinant CsCP B. subtilis spores could be easily preserved in either liquid or freeze-dried state.• Oral immunization of recombinant spores in mice could increase both local and system immune levels in a dose-dependent manner.• Oral administration of recombinant spores increased the number of beneficial bacteria and reduced the number of harmful bacteria in the intestinal tract of mice.
枯草芽孢杆菌(B. subtilis)孢子可作为表达异源抗原的理想载体,并通过口服引发特异性免疫反应。在先前的研究中,我们成功构建了表达华支睾吸虫半胱氨酸蛋白酶的重组枯草芽孢杆菌孢子(华支睾吸虫,B.s-CsCP),并证实口服B.s-CsCP可在小鼠中引发良好的保护性免疫反应。在本研究中,使用革兰氏染色观察不同形态的B.s-CsCP的形态,并比较液体孢子和冻干孢子在不同温度下的储存情况。将小鼠以三种不同剂量的孢子(2×10、1×10和5×10 CFU/天)口服免疫,共三次,间隔两周。然后,测量小鼠的抗体水平,评估孢子的安全性,并研究口服灌胃孢子(1×10剂量)后肠道微生物群的变化。结果表明,枯草芽孢杆菌是典型的革兰氏阳性菌,其孢子对化学染料具有良好的抗性。重悬于无菌水中的液体枯草芽孢杆菌孢子可在4℃或更低温度下长期保存,而冻干孢子即使在室温下也能很好地保存,在较低温度下保存效果更佳。给小鼠口服枯草芽孢杆菌孢子可剂量依赖性地刺激局部黏膜和全身免疫反应,且无毒性副作用。此外,小鼠肠道中产生丁酸盐的有益菌如气味杆菌增加,而潜在病原体如埃希氏菌-志贺氏菌减少。因此,我们的工作进一步证实,表达CsCP的枯草芽孢杆菌孢子可能是一种有前景的抗华支睾吸虫口服疫苗,具有稳定性、安全性、易于储存和促进肠道健康的优点。要点•重组CsCP枯草芽孢杆菌孢子可以很容易地以液体或冻干状态保存。•重组孢子口服免疫小鼠可剂量依赖性地提高局部和全身免疫水平。•口服重组孢子增加了小鼠肠道中有益菌的数量,减少了有害菌的数量。
Appl Microbiol Biotechnol. 2020-1-7
Front Immunol. 2025-4-3
Front Immunol. 2025-2-26
Appl Biochem Biotechnol. 2024-10
Biomed Pharmacother. 2020-1-24
Appl Microbiol Biotechnol. 2020-1-7
Appl Microbiol Biotechnol. 2019-11-22
Front Microbiol. 2019-5-9
J Microbiol Biotechnol. 2019-2-28
Appl Microbiol Biotechnol. 2018-11-5